SCHIZOPHRENIA - Nursing Case Study
Pathophysiology
• Primary mechanism: Dopamine Dysregulation - Schizophrenia is linked to an imbalance in dopamine, a neurotransmitter in the brain. Overactivity in the mesolimbic pathway can lead to positive symptoms like hallucinations and delusions, while underactivity in the mesocortical pathway may cause negative symptoms such as apathy and lack of motivation.
• Secondary mechanism: Glutamate Dysfunction - This involves reduced activity of glutamate, another neurotransmitter, particularly affecting NMDA receptors. This dysfunction may contribute to cognitive deficits and negative symptoms by disrupting normal brain signaling and neural connectivity.
• Key complication: Cognitive Impairment - Due to these neurotransmitter imbalances, patients often experience challenges in memory, attention, and problem-solving, which significantly impact daily functioning and quality of life.
Patient Profile
Demographics:
23-year-old female, college student
History:
• Key past medical history: Diagnosed with schizophrenia 6 months ago, no hospitalizations
• Current medications: Aripiprazole 10 mg daily
• Allergies: None known
Current Presentation:
• Chief complaint: Mild auditory hallucinations
• Key symptoms: Occasional hearing of voices, slight social withdrawal, but maintains daily functioning
• Vital signs: Blood pressure 118/76 mmHg, Heart rate 72 bpm, Respiratory rate 16 breaths per minute, Temperature 98.6°F, Oxygen saturation 98% on room air
Section 1
Initial Assessment Findings:
During the initial assessment, the nursing team conducts a thorough evaluation to better understand the patient's current status. The patient, a 23-year-old female college student, presents as alert and oriented to person, place, time, and situation. She maintains good eye contact during the conversation, though she occasionally glances around the room as if responding to internal stimuli. Her speech is coherent and goal-directed, with mild latency in responses. The patient reports that she has been experiencing mild auditory hallucinations, characterized by hearing indistinct voices that are not commanding or distressing but can be distracting, particularly during study sessions. Despite these hallucinations, she continues to attend classes and complete assignments, though she notes a slight decline in her academic performance.
The nursing assessment reveals no significant abnormalities in her vital signs, with blood pressure at 118/76 mmHg, heart rate at 72 bpm, respiratory rate at 16 breaths per minute, temperature at 98.6°F, and oxygen saturation at 98% on room air. A mental status examination highlights slight social withdrawal and reduced participation in social activities, which the patient attributes to feeling overwhelmed by the voices. She acknowledges subtle changes in her cognitive function, such as difficulty concentrating and occasional forgetfulness, which align with the known cognitive challenges associated with schizophrenia. However, she expresses a willingness to engage in therapeutic activities and adhere to her medication regimen, indicating a positive attitude towards managing her condition.
These assessment findings provide a comprehensive baseline for understanding the patient's current state and inform the next steps in her care plan. The nursing team can now focus on developing interventions aimed at enhancing the patient's coping strategies for managing hallucinations and supporting her cognitive function. This will involve collaboration with the healthcare team to ensure a holistic approach to care that addresses both the psychological and social aspects of her condition, ultimately aiming to improve her quality of life and academic performance.
Section 2
Response to Interventions:
Following the initial assessment, the nursing team implements a tailored care plan centered on the patient's reported auditory hallucinations and cognitive difficulties. The patient begins a regimen of low-dose antipsychotic medication, specifically risperidone at 1 mg daily, to address her mild auditory hallucinations. During a follow-up appointment two weeks later, the patient reports a noticeable reduction in the frequency and intensity of the voices, which now occur less frequently and do not interfere as much with her daily activities. She mentions feeling more comfortable attending classes and social gatherings, and her concentration during study sessions has improved slightly.
In addition to pharmacological intervention, the nursing team introduces cognitive-behavioral therapy (CBT) sessions, focusing on enhancing the patient's coping strategies for managing hallucinations and improving cognitive function. The patient actively participates in these sessions, learning techniques such as reality testing and cognitive restructuring, which help her manage distracting thoughts and focus better on tasks at hand. Her engagement and positive attitude towards the therapy indicate a promising response, as she reports feeling more in control and less overwhelmed by her symptoms.
The patient's vital signs remain stable, with no adverse effects observed from the medication. Her blood pressure is 116/74 mmHg, heart rate 70 bpm, respiratory rate 16 breaths per minute, and oxygen saturation is 98% on room air. Encouraged by these positive developments, the nursing team, in collaboration with the psychiatrist and therapist, plans to continue the current interventions while closely monitoring for any side effects or changes in her symptomatology. This approach aims to support the patient's ongoing recovery, enhance her academic performance, and improve her overall quality of life.
Section 3
Change in Patient Status:
A month into the treatment plan, the patient returns for a follow-up appointment with a sense of optimism. She reports continued improvement in managing her auditory hallucinations, which now rarely disrupt her daily routine. Her cognitive function has shown marked progress, allowing her to participate more actively in her classes and engage in social activities with her peers. The patient is more confident and expresses gratitude towards the nursing team for their support and guidance.
However, during the appointment, the patient mentions experiencing mild side effects from the risperidone, including slight drowsiness and occasional headaches. Despite these side effects, she remains committed to her treatment plan, attributing her improved quality of life to the interventions. The nursing team decides to maintain the current medication dosage but emphasizes the importance of monitoring these symptoms. They advise the patient to keep a journal of any side effects and to report any increase in severity or frequency.
In addition to medication management, the nursing team continues to encourage the patient to attend her CBT sessions, which have been pivotal in her recovery. They reinforce the importance of employing the coping strategies she has learned, such as reality testing and cognitive restructuring, to maintain her progress. The team also schedules another follow-up appointment in four weeks to reassess her condition and make any necessary adjustments to her care plan. This proactive approach ensures that the patient receives comprehensive support, promoting her long-term stability and academic success.
Section 4
At the next follow-up appointment, the nursing team conducts a thorough assessment of the patient’s current condition. Vital signs are stable: her blood pressure is 118/76 mmHg, heart rate is 72 bpm, respiratory rate is 16 breaths per minute, and temperature is 98.6°F. The patient reports that her sleep has improved, averaging about 7-8 hours per night, which is a positive change from her earlier insomnia. Her appetite remains consistent, and she continues to maintain a healthy weight.
The nursing team reviews the patient’s journal, noting that the mild drowsiness and occasional headaches she experienced as side effects of risperidone have not increased in severity. The patient mentions that these symptoms usually resolve after resting or taking a short walk. Cognitive assessments reveal continued improvement; she demonstrates greater focus and clarity in her thought processes. Her participation in cognitive-behavioral therapy (CBT) sessions remains regular, and she articulates how the techniques learned have been instrumental in managing stress and enhancing her social interactions.
In light of the patient's positive response to the current treatment plan, the nursing team decides to maintain the risperidone dosage but continues to monitor her closely for any changes in symptoms or side effects. They encourage the patient to remain vigilant in her self-monitoring and to communicate any concerns promptly. The plan is to maintain the focus on CBT and medication adherence, supporting her holistic recovery approach. The patient expresses gratitude for the support and feels empowered to continue her journey toward stability, with the next follow-up scheduled in another month to ensure continued progress and address any emerging needs.
Section 5
During the next follow-up appointment, the nursing team observes a noticeable improvement in the patient's overall demeanor and engagement. She appears more relaxed and is more actively participating in conversations about her treatment plan. Her vital signs remain stable, with a blood pressure of 116/74 mmHg, heart rate of 70 bpm, respiratory rate of 15 breaths per minute, and a temperature of 98.4°F. The patient reports feeling more energetic and motivated, attributing this change to her regular exercise routine and adherence to the structured daily schedule that she and her therapist developed during CBT sessions.
However, the patient shares a new concern regarding occasional blurred vision, particularly in the evenings. After a thorough eye examination and careful review of her current medications, the team considers the possibility that this might be a mild side effect of risperidone. To address this, the nursing team advises her to take regular breaks when reading or using screens and to ensure adequate hydration throughout the day. They also reinforce the importance of reporting any changes in her vision or other new symptoms promptly.
The patient's lab results from the recent blood tests show normal ranges for glucose, liver function, and lipid profile, which alleviates concerns about potential metabolic side effects of her medication. The nursing team decides to continue monitoring her closely, scheduling a follow-up with an ophthalmologist if the vision issues persist. They emphasize the importance of maintaining her current routines, including medication adherence and regular therapy sessions, to support her ongoing recovery. The patient remains optimistic and committed to her treatment plan, expressing confidence in her ability to manage her symptoms effectively. The next appointment is set for another month, allowing for continuous evaluation and support of her progress.